Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Shire wins US approval for kidney disease drug SHIRE Pharmaceuticals was yesterday celebrating approval from US regulators for the launch of its Fosrenol treatment for patients with kidney disease.
